Skip to main content
Journal cover image

Aprotinin versus tranexamic acid: the controversy continues.

Publication ,  Journal Article
Levy, JH
Published in: Transfusion
March 2006

Duke Scholars

Published In

Transfusion

DOI

ISSN

0041-1132

Publication Date

March 2006

Volume

46

Issue

3

Start / End Page

319 / 320

Location

United States

Related Subject Headings

  • Tranexamic Acid
  • Risk Factors
  • Retrospective Studies
  • Male
  • Humans
  • Hemostatics
  • Fibrinolysis
  • Female
  • Drug-Related Side Effects and Adverse Reactions
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levy, J. H. (2006). Aprotinin versus tranexamic acid: the controversy continues. Transfusion, 46(3), 319–320. https://doi.org/10.1111/j.1537-2995.2006.00767.x
Levy, Jerrold H. “Aprotinin versus tranexamic acid: the controversy continues.Transfusion 46, no. 3 (March 2006): 319–20. https://doi.org/10.1111/j.1537-2995.2006.00767.x.
Levy JH. Aprotinin versus tranexamic acid: the controversy continues. Transfusion. 2006 Mar;46(3):319–20.
Levy, Jerrold H. “Aprotinin versus tranexamic acid: the controversy continues.Transfusion, vol. 46, no. 3, Mar. 2006, pp. 319–20. Pubmed, doi:10.1111/j.1537-2995.2006.00767.x.
Levy JH. Aprotinin versus tranexamic acid: the controversy continues. Transfusion. 2006 Mar;46(3):319–320.
Journal cover image

Published In

Transfusion

DOI

ISSN

0041-1132

Publication Date

March 2006

Volume

46

Issue

3

Start / End Page

319 / 320

Location

United States

Related Subject Headings

  • Tranexamic Acid
  • Risk Factors
  • Retrospective Studies
  • Male
  • Humans
  • Hemostatics
  • Fibrinolysis
  • Female
  • Drug-Related Side Effects and Adverse Reactions
  • Cardiovascular System & Hematology